SCHEMBL21099819

SCHEMBL21099819

CC(C)Sc1ccccc1CNc1nc(Nc2ccc(N3CCN(C)CC3)cc2)nc2ccsc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.53
▸ BRD4 O60885 3/20 0.46
▸ JAK2 O60674 3/20 0.46
▸ PTK2 Q05397 4/20 0.45
▸ EGFR P00533 5/20 0.44
▸ ABCB11 O95342 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ DRD1 P21728 1/20 0.43
▸ TBXA2R P21731 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ PDE4A P27815 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21099825 0.91 IRAK4 (0.55) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL21099556 0.86 IRAK4 (0.56) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL21099576 0.84 PTK2 (0.52) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL19867342 0.83 BRD4 (0.53) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL19867312 0.82 PTK2 (0.61) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL21100193 0.77 IRAK4 (0.59) IRAK4BRD4JAK2EGFRLRRK2
SCHEMBL19921070 0.77 STAT6 (0.43) IRAK4JAK2EGFRSTAT6LRRK2
SCHEMBL21150147 0.75 IRAK4 (0.54) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL21099812 0.74 CCND3 (0.54) IRAK4BRD4JAK2PTK2EGFR
SCHEMBL19867315 0.74 IRAK4 (0.56) IRAK4BRD4JAK2PTK2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3498716-A1 THIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS Hongyun Biotech Co., Ltd. (CN) 2019-06-19 — — EP disclosed
Send feedback